Profile
Currently, Kimi E. Iguchi occupies the position of Chief Financial Officer & Treasurer at SAGE Therapeutics, Inc. Ms. Iguchi is also on the board of Disarm Therapeutics, Inc. She previously was Vice President-Finance of Cyberkinetics Neurotechnology Systems, Inc., Chief Operating Officer-North America Region at Santhera Pharmaceuticals Holding AG, Senior Manager-External Reporting at Biogen, Inc. and Finance Manager at Biogen MA, Inc. (a subsidiary of Biogen, Inc.), Senior Director-Finance, Reporting & Analysis at Millennium Pharmaceuticals, Inc. and Manager-Business Assurance at PricewaterhouseCoopers LLP. Ms. Iguchi received an undergraduate degree from Drew University and an MBA from Northeastern University.
Kimi Iguchi active positions
| Companies | Position | Start |
|---|---|---|
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Director/Board Member | 2018-10-24 |
Former positions of Kimi Iguchi
| Companies | Position | End |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Director of Finance/CFO | 2024-10-30 |
| SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 2011-08-31 |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Director of Finance/CFO | 2007-05-30 |
| BIOGEN INC. | Corporate Officer/Principal | 1997-12-31 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Corporate Officer/Principal | 1994-12-31 |
Training of Kimi Iguchi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Drew University
Drew University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Health Technology |
- Stock Market
- Insiders
- Kimi Iguchi
















